CorMedix Therapeutics announced interim results for the company’s ongoing real-world study of its DefenCath (taurolidine ...
The American College of Cardiology (ACC) announced that a new scientific statement on the management of peripheral artery dise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback